Deliverics Ltd is a provider of R&D kits to Life Science researchers enabling them to deliver molecules into and onto cells. Deliverics launched its first product, a biodegradable transfection kit SAFEctinTM, in November 2010 and launched its second product, SAFEctinTMSTEM in 2011 optimised for stem cell transfection.
Deliverics’ patented compounds are virtually non toxic to cells and do not require removal or change of culture medium post transfection, resulting in a simple one step protocol. The naturally degrading compounds also offer higher transfection efficiencies of nucleic acids compared to current market leaders.
Deliverics is keen to work closely with those working in the field of Stem Cell enabling faster, simpler and more efficient results for challenging transfection processes. Put simply, our aim is to take the pain out of transfection.